Skip to content

Integrated Chinese and Western Therapy for Cancer-Related Fatigue

Clinical Effectiveness Assessment of Integrated Chinese and Western Therapy for Cancer-Related Fatigue

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07445243
Enrollment
86
Registered
2026-03-03
Start date
2019-11-08
Completion date
2020-04-22
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related Fatigue, Neoplasms (Cancer / Tumors)

Keywords

Holistic care, Integrative medicine, Integrated Chinese and Western medicine, Traditional Chinese Medicine, Chinese herbal medicine, Sleep hygiene, Aromatherapy, Nutrition counseling, Oncology nursing, Cancer-related fatigue

Brief summary

Cancer-related fatigue (CRF) is a common and debilitating symptom in patients with cancer. Evidence-based non-pharmacological approaches include sleep hygiene, physical activity, nutritional management, and traditional Chinese medicine (TCM). This study evaluates the clinical effectiveness of an interdisciplinary holistic program integrating Chinese and Western therapies for CRF among hospitalized cancer patients receiving integrated care. Approximately 100 participants will be enrolled and followed for up to 3 months.

Detailed description

Eligible hospitalized cancer patients receiving integrated Chinese and Western care will be enrolled after providing informed consent. Participants will complete a CRF questionnaire and receive a non-invasive holistic integrative care program, including patient education, sleep hygiene, exercise guidance, nutritional assessment/intervention, and TCM-related care. The primary endpoint is change in CRF score. Secondary endpoints include TCM constitution assessment, vital signs, anthropometrics, complete blood count, and liver/renal function tests. Participants will be followed for 3 months from enrollment.

Interventions

OTHERIntegrated Chinese and Western Holistic Care Program

An interdisciplinary integrative care program combining Western supportive care and Traditional Chinese Medicine to manage cancer-related fatigue in hospitalized oncology patients. Core components include fatigue assessment, patient education and symptom management guidance, sleep hygiene, exercise encouragement, aromatherapy and/or massage, nutrition assessment and counseling, and shared decision-making. Traditional Chinese Medicine consultation may provide acupuncture and/or Chinese herbal medicine according to patient needs and clinical judgment.

Sponsors

Taichung Tzu Chi Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Single-group, nonrandomized, open-label, quasi-experimental evaluation of an interdisciplinary holistic care program for hospitalized adult patients with cancer-related fatigue. The program integrates nursing education, sleep hygiene (optional aromatherapy), exercise promotion, dietician consultation, and Traditional Chinese Medicine modalities.

Eligibility

Sex/Gender
ALL
Age
20 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Inclusion Criteria: Signed informed consent form. Age 20 to 95 years. Receiving integrated Chinese and Western holistic care. Agree to provide clinically relevant data for this study.

Exclusion criteria

Refuse to continue participation during the study period, or the family requests discontinuation (withdrawal). Psychiatric disorder that makes the participant unable to cooperate.

Design outcomes

Primary

MeasureTime frameDescription
Change in Cancer-Related Fatigue (CRF) Score (0-10)From admission (baseline) through discharge (last in-hospital assessment; up to 30 days)CRF is assessed using the Taiwan Society of Cancer Palliative Medicine fatigue scale (0-10) during hospitalization. Peak CRF score is defined as the maximum recorded CRF score from admission to discharge. Discharge CRF score is defined as the last in-hospital CRF assessment prior to discharge. The primary outcome is the within-participant change in CRF score from peak to discharge.

Secondary

MeasureTime frameDescription
Proportion of Participants With Moderate-to-Profound CRF at Discharge (CRF Score ≥4)At discharge (last in-hospital assessment; up to 30 days after admission)Percentage of participants whose discharge CRF score is ≥4 (moderate or above) on the Taiwan Society of Cancer Palliative Medicine fatigue scale (0-10).
Distribution of CRF Severity Categories at Discharge (0, 1-3, 4-6, 7-8, 9-10)At discharge (last in-hospital assessment; up to 30 days after admission)Distribution of discharge CRF scores categorized as 0, 1-3, 4-6, 7-8, and 9-10 on the Taiwan Society of Cancer Palliative Medicine fatigue scale.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026